000 01336 a2200325 4500
005 20250516113046.0
264 0 _c20130510
008 201305s 0 0 eng d
022 _a1879-0070
024 7 _a10.1016/j.diagmicrobio.2012.08.024
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJones, Ronald N
245 0 0 _aUpdate on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).
_h[electronic resource]
260 _bDiagnostic microbiology and infectious disease
_cJan 2013
300 _a107-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aCephalosporins
_xpharmacology
650 0 4 _aLongitudinal Studies
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aPneumococcal Infections
_xmicrobiology
650 0 4 _aStreptococcus pneumoniae
_xdrug effects
650 0 4 _aUnited States
650 0 4 _aCeftaroline
700 1 _aSader, Helio S
700 1 _aMendes, Rodrigo E
700 1 _aFlamm, Robert K
773 0 _tDiagnostic microbiology and infectious disease
_gvol. 75
_gno. 1
_gp. 107-9
856 4 0 _uhttps://doi.org/10.1016/j.diagmicrobio.2012.08.024
_zAvailable from publisher's website
999 _c22133600
_d22133600